ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
The purpose of this study is to investigate if intramuscular PEG-asparaginase administered either at six or two week intervals from day 92 until 8 months from diagnosis for patients with non-HR ALL will result in equal probability of Event Free Survival
Epistemonikos ID: 9ca3c26d828e9b8a7a8d5a14bd70352b95d2aa23
First added on: Jan 21, 2022